Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

AMSilk

Explore full profile

The world’s first industrial supplier of vegan silk biopolymers and has its headquarters in Planegg near Munich, Germany

Planegg, GermanyFounded 2008Biotech & Life Sciences
Valuation $250–500M Last recorded · 2025
Revenue <$1M Latest reported FY
Headcount <100 Current team size
Total funding $100–500M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for AMSilk and the history behind them.

About AMSilk

AMSilk is a biotechnology company that specializes in the production of bioengineered silk proteins. These innovative materials are designed to be sustainable, high-performing, and capable of addressing global challenges. The company operates in the burgeoning biotech materials market, serving a diverse range of clients across various industries.

AMSilk's business model revolves around the production and distribution of these silk proteins, which are renewable, biodegradable, fully recyclable, and have a lower carbon footprint compared to traditional materials. The company's products offer superior performance to petroleum-based, animal-based, or other natural alternatives, making them an attractive choice for businesses looking to reduce their environmental impact.

The company generates revenue through the sale of these materials, either as non-customized products or as part of joint research and development projects. AMSilk also offers a strategic partnership model, where industry leaders can collaborate with the company to develop tailor-made products based on their specific needs.

AMSilk's innovative approach to protein production has resulted in a new strain that delivers unprecedented yield with greater efficiency and lower costs. This has positioned the company as a world-leading provider of structural proteins, and it continues to scale up its operations to meet growing demand.

In summary, AMSilk is a forward-thinking biotech company that is leveraging the power of silk proteins to create sustainable and high-performing materials. Its collaborative approach to business and commitment to sustainability make it a major player in the biotech materials market.

Source: Dealroom company data

At a glance

Status
Operational
Founded
2008
Headquarters
Planegg, Germany
Employees
81
Open positions
2
Dealroom signal
75.5/100
Industry
Health, Fashion
Sub-industry
BioTechnology, Medical Devices
Sector
Biotech & Life Sciences, Publishing, Biotechnology, Synthetic Biology, Spinout, Sustainable Development Goals, Industrial Technology, Tech for Hospitals and Clinics
Technology
Deep Tech
Business model
Manufacturing
Client focus
b2b

Funding history

6 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
LATE VCOther financing Sep 2025 $57M $229M Novo Holdings · MIG Capital · Athos ↗
SERIES COther financing Apr 2023 $28M $160M Cargill Ventures ↗
Showing the latest 2 of 6 recorded eventsBook a demo for the full funding history →

Financials

Revenue, earnings and profit over time

Revenue, earnings and other financial measures where available. Years marked “E” are estimates.

Company filings, research estimates and Dealroom dataBook a demo for the full financial model →

Growth signals

AMSilk website traffic

Latest recorded traffic for AMSilk is 1.4K monthly website visits, down 70.2% over the last three months. AMSilk's team grew 1.3% over the past year.

Latest monthly visits1.4K 3-month web change-70.2% 1-year team growth+1.3%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Investors

5 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A1 investor entered at this stage

  • MIG Capital

Series B and later3 investors entered at this stage

  • Cargill Ventures
  • Athos
  • Novo Holdings

Other known investors1 additional known investor

  • Technical University Munich
Team profiled 14 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 2 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
7 countries with
team presence
🇩🇪 Germany82%
🇮🇹 Italy3.3%
🇳🇱 Netherlands3.3%
🇸🇰 Slovakia3.3%
🇨🇭 Switzerland3.3%
Top 5 of 7 shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about AMSilk on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See AMSilk’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.